Curia Expands Cell Line Development Offering with CHOZN Platform
Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies ALBANY, N.Y.,…
Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies ALBANY, N.Y.,…
Single API Integration Delivers Tech-first Access Solutions, Comprehensive Program Insights and Reduced Implementation Time ORLANDO,…
Single API Integration Delivers Tech-first Access Solutions, Comprehensive Program Insights and Reduced Implementation Time ORLANDO,…
MIAMI, June 20, 2023 (GLOBE NEWSWIRE) — ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), a…
YONKERS, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
MIAMI, June 20, 2023 (GLOBE NEWSWIRE) — ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), a…
BOSTON, June 20, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
YONKERS, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
BOSTON, June 20, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
SAN DIEGO and SUZHOU and SHANGHAI, China, June 20, 2023 (GLOBE NEWSWIRE) — Gracell Biotechnologies…
SAN DIEGO and SUZHOU and SHANGHAI, China, June 20, 2023 (GLOBE NEWSWIRE) — Gracell Biotechnologies…
Webcast Link Available at PaxMedica.com TARRYTOWN, NY, June 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire…
Webcast Link Available at PaxMedica.com TARRYTOWN, NY, June 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire…
MISSISSAUGA, Ontario, June 20, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
MISSISSAUGA, Ontario, June 20, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Grant Funding received to date from the Australian Federal Government totals USD $3.25 million NEW…
Grant Funding received to date from the Australian Federal Government totals USD $3.25 million NEW…
FREMONT, CA, June 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
FREMONT, CA, June 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
Sequantrix identifies and validates novel, antifibrotic targets by leveraging one of the world’s largest human…